About me
Lisa Ursella Collins is Co-Founder and CEO of Innomas Clinical Research and a global clinical operations and program leader. She works at the intersection of clinical execution, quality, and operational risk—translating development strategy into disciplined delivery. Through Innomas, she collaborates with sponsors to execute complex, multinational trials and leads a contracted site network across Africa designed to deliver scalable, inspection-ready research. Her focus is building execution models that protect participants, withstand scrutiny, and produce data trusted at the highest levels of global science.
